Purchase Order W81K0024P0003
Award Date
10/1/24
Potential Completion Date
9/30/25
Potential Value
$169K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Biomerieux Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for "ORGANISM GN/GP IDENTIFICATION" services. The $245,279.50 contract runs from October 1, 2021, through September 30, 2026, and does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. Division, provides a range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the...
This federal contract award, valued at $822,015.40, was issued by the Defense Health Agency to Biomerieux Inc. through its Biomerieux, Inc. Division. The contract is for the provision of GN TEST KIT/AST-GN95 PN 421982, with a period of performance through September 30, 2024. The original solicitation was a sole-source Special Notice from the Department of the Army Medical Command, which justified the award to Biomerieux as the only source able to meet the technical and interface requirements for...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned for-profit manufacturer of clinical diagnostic products. The contract is to provide Biomerieux reagents and supplies to be used with government-owned analyzers, as well as the lease of a Virtuo B-Unit module, for the period of October 1, 2022 to September 30, 2023. The potential value of the contract is $249,612.61. This procurement was a sole source award under FAR...
This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $11,258.96, is for the provision of Biomerieux supplies and services, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated reagents and test kits. Biomerieux, through its Biomerieux, Inc. division, has been a long-standing supplier of clinical diagnostic equipment and consumables to various...
The Department of the Army Medical Command awarded a firm fixed-price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer, for VITEK 2 GN & GP AST Cards on May 11, 2020. The potential value of the contract is $204,756.00, with a completion date of March 31, 2021. This was a sole source contract issued under the authority of Federal Acquisition Regulation 13.106 (b) (1) to provide reagents and consumables compatible with the government-owned Biomerieux equipment for...
This is a federal contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of reagents, materials, and test supplies. The $15,370.43 firm-fixed-price contract has an ultimate completion date of October 15, 2024. Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the Departments of Veterans Affairs,...
This $212,471.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of Biomerieux's proprietary microbiology analyzer equipment, reagents, and technical support services to enable infectious disease testing and identification. This award is associated with Biomerieux's existing indefinite delivery contracts and blanket purchase agreements...
This is a firm-fixed-price purchase order awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic products. The $247,451 contract is for the provision of GN TEST KIT/AST GNB95 421982 20 CARDS, which are likely microbiological testing solutions used for medical applications. The award does not have a set-aside designation. Biomerieux Inc. has provided various clinical diagnostic testing products, equipment, and...
This is a firm-fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $16,879.50, is for the provision of Biomerieux's proprietary diagnostic platforms, reagents, and test kits to support the agency's infectious disease testing and pathogen detection requirements. The contract does not have a set-aside designation, as Biomerieux is often the sole source provider for its specialized...
This is a firm-fixed-price purchase order awarded by the Medical Command (MEDCOM) of the U.S. Department of the Army to Biomerieux Inc., through its Biomerieux, Inc. division, for GN/AST GENERIC GN AST 20 CARDS/BOX. The contract has a ceiling value of $1,774,041.62 and a period of performance through September 30, 2026. The contract was awarded under a pre-solicitation opportunity that sought proposals to establish a cost-per-test arrangement for automated microbial identification and...